Theralink Technologies, Inc.
THER · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $1 | $0 | $0 | $0 |
| + Debt | $20 | $13 | $13 | $7 |
| Enterprise Value | $19 | $13 | $13 | $7 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -11.4% | 0% | 19.2% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 77.7% | 75.3% | 75.3% | 85% |
| EBITDA | -$2 | -$2 | -$2 | -$2 |
| % Margin | -1,385.7% | -805.6% | -805.6% | -1,232.2% |
| Net Income | $10 | $5 | $5 | -$20 |
| % Margin | 5,363.6% | 2,222.8% | 2,222.8% | -11,707.9% |
| EPS Diluted | 0.002 | 0 | 0 | -0.003 |
| % Growth | 700% | 0% | 106.3% | – |
| Operating Cash Flow | -$2 | -$1 | -$1 | -$2 |
| Capital Expenditures | -$0 | $0 | $0 | -$0 |
| Free Cash Flow | -$2 | -$1 | -$1 | -$2 |